Essential

Subscribe today for access to
Articles and Reports

By Tara Cepull, MA | Dec 18, 2024 | 1 min read

Revenue cycle management experts weigh in on the biggest developments of 2024 and how labs can best prepare for 2025 and beyond

Cases filed or resolved by the U.S. Department of Justice in the fourth quarter reveal the same compliance issues from early in 2024

By Michael Schubert, PhD | Dec 18, 2024 | 1 min read

ADLM president Anthony Killeen looks at labs’ staffing struggles in 2024 and what can be done to alleviate them in the coming year

By Glenn S. Demby | Jul 31, 2023 | 1 min read

Ruling could spell good news for labs and other healthcare providers targeted by whistleblowers in False Claims Act qui tam lawsuits.

By Glenn S. Demby | Jul 31, 2023 | 1 min read

False billing of urine drug tests (UDTs) continues to be a focus for enforcement agencies in 2023, here’s how to avoid compliance issues.

By Glenn S. Demby | Jul 31, 2023 | 1 min read

Here’s what to know about the new codes that CMS recently added to the national HCPCS table as well as which ones were removed.

By Glenn S. Demby | Jul 5, 2023 | 1 min read

Key approvals announced in June represented important steps forward for the lab testing industry.

By Glenn S. Demby | Jul 5, 2023 | 1 min read

The outlook of the global genetic testing market based on recent reports from five financial consulting firms.

By Glenn S. Demby | Jul 4, 2023 | 1 min read

After an eventful month in the Illumina-GRAIL saga, the story may soon be over.

Recent developments pose reimbursement and compliance challenges for billing and coding infectious disease testing—here’s how to manage them.

By Glenn S. Demby | Jul 4, 2023 | 1 min read

The national retailer recently signed a deal with Simple HealthKit to provide Walmart customers online access to at-home diagnostic test kits.

By Rachel Muenz | Jul 4, 2023 | 1 min read

Though UDT-related enforcement actions predominate, an uncommon vendor-related case was in the mix this month.

By Glenn S. Demby | Jul 4, 2023 | 1 min read

Recent cases involve COVID-19 fraud, UDTs, and the latest HIPAA Right of Access settlement.